• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱内脂质体注射肉毒毒素 A 治疗氯胺酮诱导膀胱炎的潜在孤儿药疗法:通过黏膜保护和抗炎作用的大鼠模型研究。

Potential Orphan Drug Therapy of Intravesical Liposomal Onabotulinumtoxin-A for Ketamine-Induced Cystitis by Mucosal Protection and Anti-inflammation in a Rat Model.

机构信息

Division of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

出版信息

Sci Rep. 2018 Apr 11;8(1):5795. doi: 10.1038/s41598-018-24239-9.

DOI:10.1038/s41598-018-24239-9
PMID:29643467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5895575/
Abstract

Ketamine abusers may develop ulcerative cystitis and severe lower urinary tract symptoms, which is a medical dilemma. Recently, researchers have found the endemic of ketamine-induced cystitis worldwide. The intravesical administration of liposome-encapsulated onabotulinumtoxinA (Lipotoxin) might facilitate the healing of the damaged urothelium from liposomes, and reduce the urinary symptoms by onabotulinumtoxinA-induced chemo-denervation. Using female Sprague-Dawley rats, we investigated the effects of Lipotoxin on ketamine-induced cystitis. Functional magnetic resonance imaging, metabolic cage study, and cystometry were conducted. Paraffin-embedded sections were stained. The bladder mucosa and muscle proteins were assessed through Western blotting. We observed that repeated intravesical Lipotoxin instillation could improve suburothelial hemorrhage, recover the urothelial tight junction and adhesion proteins (zonula occludens-1 and E-cadherin), ensure less substance P in the urothelium, inhibit the overexpression of inflammatory mediators (IL-6, TNF-α, nuclear NF-κB, and COX-2) in the detrusor, suppress the upregulation of the mucosal TRPV1 and detrusor M-mAChR, and ameliorate bladder overactivity in the ketamine-treated rats. These data reveal the mechanisms underlying the action of Lipotoxin in ketamine-induced cystitis of rats, which provide a basis of Lipotoxin for further treating ketamine-induced cystitis in humans.

摘要

氯胺酮滥用者可能会出现溃疡性膀胱炎和严重的下尿路症状,这是一个医学难题。最近,研究人员发现了氯胺酮诱导的膀胱炎在全球范围内的流行。脂质体包裹的肉毒杆菌毒素 A(Lipotoxin)腔内给药可能通过脂质体促进受损尿路上皮的愈合,并通过肉毒杆菌毒素 A 诱导的化学去神经作用减轻尿路症状。我们使用雌性 Sprague-Dawley 大鼠研究了 Lipotoxin 对氯胺酮诱导的膀胱炎的影响。进行了功能磁共振成像、代谢笼研究和膀胱测压。对石蜡包埋切片进行染色。通过 Western blot 评估膀胱黏膜和肌肉蛋白。我们观察到,重复膀胱内 Lipotoxin 滴注可以改善黏膜下出血,恢复尿路上皮紧密连接和黏附蛋白(闭锁蛋白-1 和 E-钙黏蛋白),确保尿路上皮中 P 物质减少,抑制逼尿肌中炎症介质(IL-6、TNF-α、核 NF-κB 和 COX-2)的过度表达,抑制黏膜 TRPV1 和逼尿肌 M-型 M 受体的上调,并改善氯胺酮处理大鼠的膀胱过度活动。这些数据揭示了 Lipotoxin 在大鼠氯胺酮诱导膀胱炎中的作用机制,为 Lipotoxin 进一步治疗人类氯胺酮诱导的膀胱炎提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5895575/8b1761a81602/41598_2018_24239_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5895575/428b18959985/41598_2018_24239_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5895575/c89411a80cce/41598_2018_24239_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5895575/dc569a1e861f/41598_2018_24239_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5895575/8b1761a81602/41598_2018_24239_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5895575/428b18959985/41598_2018_24239_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5895575/c89411a80cce/41598_2018_24239_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5895575/dc569a1e861f/41598_2018_24239_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5895575/8b1761a81602/41598_2018_24239_Fig4_HTML.jpg

相似文献

1
Potential Orphan Drug Therapy of Intravesical Liposomal Onabotulinumtoxin-A for Ketamine-Induced Cystitis by Mucosal Protection and Anti-inflammation in a Rat Model.膀胱内脂质体注射肉毒毒素 A 治疗氯胺酮诱导膀胱炎的潜在孤儿药疗法:通过黏膜保护和抗炎作用的大鼠模型研究。
Sci Rep. 2018 Apr 11;8(1):5795. doi: 10.1038/s41598-018-24239-9.
2
Ba-Wei-Die-Huang-Wan (Hachimi-jio-gan) can ameliorate ketamine-induced cystitis by modulating neuroreceptors, inflammatory mediators, and fibrogenesis in a rat model.八味地黄丸(知柏地黄丸)可通过调节神经受体、炎症介质和纤维发生来改善大鼠模型中的氯胺酮诱导的膀胱炎。
Neurourol Urodyn. 2019 Nov;38(8):2159-2169. doi: 10.1002/nau.24165. Epub 2019 Sep 20.
3
A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.一项前瞻性、多中心、双盲、随机临床试验,研究脂质体配方奥昔布宁毒素 A 膀胱灌注治疗间质性膀胱炎/膀胱疼痛综合征。
J Urol. 2017 Aug;198(2):376-382. doi: 10.1016/j.juro.2017.02.021. Epub 2017 Feb 12.
4
Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: a single-center study.包载单剂量肉毒毒素 A 型的脂质体治疗膀胱过度活动症的初步研究:单中心研究。
Eur Urol. 2014 Jun;65(6):1117-24. doi: 10.1016/j.eururo.2014.01.036. Epub 2014 Feb 11.
5
Complete reversal of the clinical symptoms and image morphology of ketamine cystitis after intravesical hyaluronic acid instillation: A case report.膀胱内注射透明质酸后氯胺酮膀胱炎临床症状及影像形态完全逆转:一例报告
Medicine (Baltimore). 2018 Jul;97(28):e11500. doi: 10.1097/MD.0000000000011500.
6
Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1.氯胺酮诱导的膀胱纤维化涉及由转化生长因子-β1介导的上皮-间质转化。
Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F961-F972. doi: 10.1152/ajprenal.00686.2016. Epub 2017 Mar 22.
7
What urologists need to know about ketamine-induced uropathy: A systematic review.关于氯胺酮相关性尿毒性,泌尿科医生需要知道些什么:系统综述。
Neurourol Urodyn. 2020 Apr;39(4):1049-1062. doi: 10.1002/nau.24341. Epub 2020 Mar 25.
8
Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum.氯胺酮诱发的溃疡性膀胱炎和膀胱细胞凋亡涉及由线粒体和内质网介导的氧化应激。
Am J Physiol Renal Physiol. 2015 Aug 15;309(4):F318-31. doi: 10.1152/ajprenal.00607.2014. Epub 2015 Jun 24.
9
Therapeutic Effect of Platelet-Rich Plasma Improves Bladder Overactivity in the Pathogenesis of Ketamine-Induced Ulcerative Cystitis in a Rat Model.富血小板血浆治疗改善氯胺酮诱导的溃疡性膀胱炎大鼠模型中膀胱过度活动的疗效。
Int J Mol Sci. 2022 May 21;23(10):5771. doi: 10.3390/ijms23105771.
10
Possible pathophysiology of ketamine-related cystitis and associated treatment strategies.氯胺酮相关性膀胱炎的可能病理生理学及相关治疗策略。
Int J Urol. 2015 Sep;22(9):816-25. doi: 10.1111/iju.12841. Epub 2015 Jun 18.

引用本文的文献

1
Advancements in the management of overactive bladder in women using nano-botulinum toxin type A: A narrative review.使用纳米A型肉毒杆菌毒素治疗女性膀胱过度活动症的进展:一项叙述性综述。
Curr Urol. 2025 Mar;19(2):77-83. doi: 10.1097/CU9.0000000000000272. Epub 2025 Jan 21.
2
Management Strategies for Patients with Non-Infectious Cystitis: A Review of the Literature.非感染性膀胱炎患者的管理策略:文献综述。
Curr Urol Rep. 2024 Sep 30;26(1):6. doi: 10.1007/s11934-024-01236-2.
3
Promising Experimental Treatment in Animal Models and Human Studies of Interstitial Cystitis/Bladder Pain Syndrome.

本文引用的文献

1
The Immunomodulatory Imbalance in Patients with Ketamine Cystitis.氯胺酮相关性膀胱炎患者的免疫调节失衡。
Biomed Res Int. 2017;2017:2329868. doi: 10.1155/2017/2329868. Epub 2017 Oct 24.
2
A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.一项前瞻性、多中心、双盲、随机临床试验,研究脂质体配方奥昔布宁毒素 A 膀胱灌注治疗间质性膀胱炎/膀胱疼痛综合征。
J Urol. 2017 Aug;198(2):376-382. doi: 10.1016/j.juro.2017.02.021. Epub 2017 Feb 12.
3
Maternal Fructose Exposure Programs Metabolic Syndrome-Associated Bladder Overactivity in Young Adult Offspring.
在间质性膀胱炎/膀胱疼痛综合征的动物模型和人体研究中具有前景的实验性治疗方法。
Int J Mol Sci. 2024 Jul 23;25(15):8015. doi: 10.3390/ijms25158015.
4
Ketamine cystitis following ketamine therapy for treatment-resistant depression - case report.氯胺酮治疗难治性抑郁症后发生膀胱炎 - 病例报告。
BMC Psychiatry. 2024 Jan 2;24(1):9. doi: 10.1186/s12888-023-05468-3.
5
Pathophysiology, clinical presentation, and management of ketamine-induced cystitis.氯胺酮所致膀胱炎的病理生理学、临床表现及管理
Tzu Chi Med J. 2023 Jun 13;35(3):205-212. doi: 10.4103/tcmj.tcmj_94_23. eCollection 2023 Jul-Sep.
6
Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases.纳米技术作为推动非肿瘤性泌尿生殖系统疾病研究与治疗的工具。
Ther Adv Urol. 2022 Jul 26;14:17562872221109023. doi: 10.1177/17562872221109023. eCollection 2022 Jan-Dec.
7
Nano-BTA: A New Strategy for Intravesical Delivery of Botulinum Toxin A.纳米BTA:膀胱内注射A型肉毒杆菌毒素的新策略。
Int Neurourol J. 2022 Jun;26(2):92-101. doi: 10.5213/inj.2142124.062. Epub 2022 Jun 30.
8
Molecular Pathophysiology and Potential Therapeutic Strategies of Ketamine-Related Cystitis.氯胺酮相关性膀胱炎的分子病理生理学及潜在治疗策略
Biology (Basel). 2022 Mar 24;11(4):502. doi: 10.3390/biology11040502.
9
BoNT/A in the Urinary Bladder-More to the Story than Silencing of Cholinergic Nerves.肉毒毒素 A 作用于膀胱——不仅仅是抑制胆碱能神经。
Toxins (Basel). 2022 Jan 12;14(1):53. doi: 10.3390/toxins14010053.
10
Smaller bladder capacity and stronger bladder contractility in patients with ketamine cystitis are associated with elevated TRPV1 and TRPV4.在氯胺酮相关性膀胱炎患者中,较小的膀胱容量和较强的膀胱收缩力与 TRPV1 和 TRPV4 的升高有关。
Sci Rep. 2021 Mar 4;11(1):5200. doi: 10.1038/s41598-021-84734-4.
母体果糖暴露导致成年后代代谢综合征相关膀胱过度活动症。
Sci Rep. 2016 Oct 5;6:34669. doi: 10.1038/srep34669.
4
Ketamine abuse potential and use disorder.氯胺酮的滥用潜力和使用障碍。
Brain Res Bull. 2016 Sep;126(Pt 1):68-73. doi: 10.1016/j.brainresbull.2016.05.016. Epub 2016 May 31.
5
NMDAR inhibition-independent antidepressant actions of ketamine metabolites.氯胺酮代谢物的非NMDAR抑制依赖性抗抑郁作用。
Nature. 2016 May 26;533(7604):481-6. doi: 10.1038/nature17998. Epub 2016 May 4.
6
Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action.A型肉毒毒素与下尿路功能障碍:病理生理学及作用机制
Toxins (Basel). 2016 Apr 21;8(4):120. doi: 10.3390/toxins8040120.
7
Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction.脂质体以及脂质体包裹的肉毒杆菌毒素和他克莫司在治疗膀胱功能障碍中的潜在作用。
Toxins (Basel). 2016 Mar 18;8(3):81. doi: 10.3390/toxins8030081.
8
Ba-Wei-Die-Huang-Wan (Hachimi-jio-gan) can ameliorate cyclophosphamide-induced ongoing bladder overactivity and acidic adenosine triphosphate solution-induced hyperactivity on rats prestimulated bladder.八味地黄丸(知柏地黄丸)可改善环磷酰胺诱导的持续膀胱过度活动和酸性三磷酸腺苷溶液诱导的预刺激膀胱过度活动的大鼠活性。
J Ethnopharmacol. 2016 May 26;184:1-9. doi: 10.1016/j.jep.2015.12.026. Epub 2015 Dec 21.
9
Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum.氯胺酮诱发的溃疡性膀胱炎和膀胱细胞凋亡涉及由线粒体和内质网介导的氧化应激。
Am J Physiol Renal Physiol. 2015 Aug 15;309(4):F318-31. doi: 10.1152/ajprenal.00607.2014. Epub 2015 Jun 24.
10
Possible pathophysiology of ketamine-related cystitis and associated treatment strategies.氯胺酮相关性膀胱炎的可能病理生理学及相关治疗策略。
Int J Urol. 2015 Sep;22(9):816-25. doi: 10.1111/iju.12841. Epub 2015 Jun 18.